Is free prostate-specific antigen helpful in the differential diagnosis of benign hyperplasia and cancer of the prostate?

Tumor Biology

Volumn 18, Issue 2, 1997, Pages 80-87

  Reiter, W ^a   Stieber, P ^a   Schmeller, N ^a   Nagel, D ^a   Schambeck, C ^a   Fateh Moghadam, A ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Free Prostate carcinoma Benign hyperplasia of the; Prostate; Prostate specific antigen; Total Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY;

EID: 0031036077     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1159/000218017     Document Type: Article

References (22)

1. Ablin RJ, Soanes WA, Bronson P, Witebsky E: Precipitating antigens of the normal human prostate, J Re-prod Fcrtil 1970;22:573-574.
2. Wang MC, Papsidero LD, Kuriya-ma M, Valenzuela LA, Murphy GP, Chu TM: Prostate antigen: A new potential marker for prostatic cancer, Prostate 1981;2:89-96.
3. Oesterling JE: Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate, J Urol 1991;145:907-923.
4. Partin AW, Oesterling JE: The clinical usefulness of prostate specific antigen: Update 1994, J Urol 1994; 152:1358-1368.
5. Fatch-Moghadam A, Stieber P: Sensible Use of Tumour Markers, ed 2, Marloffstein-Rathsberg, Hartmann, 1993.
6. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tukkanen K, Alfthan O: A complex between prostate-specific antigen and alphai-antichy-motrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer, Cancer Res 1991; 51:222-226.
7. r antichymotrypsin, Clin Chem 1991; 37:1618-1625.
8. Catalona WJ, Smith DS: Comparison of different serum prostate specific antigen measures for early prostate cancer detection, Cancer 1994; 74:1516-1518.
9. Partin AW, Kelly CA, Subong ENP, Walsh PC, Chan DW, Wang TJ, Rit-tenhouse HG, Wolfert RL, Norton KC, McCormack R: Measurement of the ratio of free PSA to total PSA improves prostate cancer detection for men with total PSA levels between 4 and lOng/ml (abstract), J Urol 1995; 153:295.
10. Prestigiacomo AF, Stamcy TA: Clinical usefulness of free and com-plexed PSA, Scand J Clin Lab Invest 1995;55(suppl 221):323-324.
11. Van Dalcn A: Quality control and standardization of tumour marker tests, T umor Biol 1993;14:131-135.
12. Kojima M, Babaian RJ: Algo-rithmus for early detection of prostate cancer, Current state of the ‘art’, Cancer 1995;75(suppl 7): 1860-1868.
13. Oesterling JE: Prostate specific antigen: Its role in the diagnosis and staging of prostate cancer, Cancer 1995;75(suppl 7): 1795-1804.
14. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan PC, dc Kernion JB, Ratliff TL, Kavousi LR, Dalkin BL, Walters WB, Mac Farlane MT, South-wich PC: Comparison of digital examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men, J Urol 1994;151:1283-1290.
15. Wu JT, Wilson L, Zhang P, Meikle AW, Stephenson R: Correlation of serum concentration of PS A-ACT complex with total PSA in random and serial specimens from patients with BPH and prostate cancer, J Clin Lab Anal 1995;9:15-24.
16. Wu JT: Assay for proslate specific antigen (PSA) problems and possible solutions, J Clin Lab Anal 1994; 8:51-62.
17. Vcssclla RL: Trends in immunoassays of prostate specific antigen: Scrum complexes and ultrasensitivity, ClinChem 1993:39:2035-2039.
18. Wang TJ, Hill T, Norton K, Sokoloff R, Frankcnnc F, Rittcnhouse HG, Wolfert RL: Specific immunoassays for free PSA and its clinical relevance, J Urol 1995;153(suppl): 295A.
19. Wilson L, Stephenson R, Mciklc W, Wu J: Measurement of serum PSA-ACT complex in patients with BPH and prostate cancer: Feasibility and advantages, Clin Chcm 1994;40: 1004.
20. Dcnsel M, Rittenhouse H, Cazares L, Wolfert R: Detection of prostate specific antigen complexcd to alpha 1-antichymotrypsin (PSA/ACT) and uncomplexed PSA in serum from patients with benign prostate hypertrophy (BPH) and prostate cancer (PCA) using dual monoclonal assays, J Urol 1993;149:333A.
21. Strobel SA, Sokoloff RL, Wofert RL, Rittcnhouse HG: Multiple forms of prostate-specific antigen in scrum measured differently in equimolar-and skewed-response assays, Clin Chem 1995;41:125-126.
22. Schambcck CM, Schmeller N, Stie-ber P, Jansen HM, Pahl H, Schneider W, Fateh-Moghadam A: Methodological and clinical comparison of the ACS prostate-specific antigen assay and the Tandcm-E prostate-specific antigen in prostate cancer, Urology 1995;46:195-199.